PetIQ, Inc. Announces Resignation of Ronald Kennedy as Director
July 06, 2021 at 05:21 pm
Share
PetIQ, Inc. announced that the conditional resignation of Mr. Ronald Kennedy as a director of company is incorporated herein by reference. This conditional resignation has been submitted solely in connection with the company’s majority vote policy for in the company’s bylaws. Mr. Kennedy’s conditional resignation was not the result of any dispute or disagreement with the company or the board on any matter relating to the operations, policies or practices of the company.
PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segmentâs services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.
PETIQ, INC. 
